Clarity, clinical applicability and relevance of absolute contraindications in official 'Summaries of Product Characteristics' (SmPCs) (2022) Andrikyan W, Then M, Dürr P, Jung-Poppe L, Schuster A, Weisbach L, Farker K, et al. Conference contribution Improved, but still limited coding of medication-related problems - application of the new WHO ICD-11 code-set to clinical routine data (2022) Jung-Poppe L, Andrikyan W, Altenbuchner A, Pfistermeister B, Dormann H, Fromm M, Maas R Conference contribution Development and validation of an LC-MS method for drug exposure measurement of 57 oral antitumor drugs in human plasma (2022) Kehl N, Dürr P, Schlichtig K, Maas R, Fromm M, Geßner A, Taudte V Conference contribution Medication safety of new oral antitumor agents: a randomized trial on the impact of a clinical pharmacological / pharmaceutical intervention on drug-related problems and patient safety (2019) Schlichtig K, Duerr P, Dörje F, Fromm F Conference contribution Role of (-)-epigallocatechin gallate in the pharmacokinetic interaction between nadolol and green tea in healthy volunteers (2018) Abe O, Ono T, Sato H, Mueller F, Ogata H, Miura I, Shikama Y, et al. Journal article N(1)-methylnicotinamide as an endogenous probe for drug interactions by renal cation transporters: studies on the metformin-trimethoprim interaction (2015) Mueller F, Pontones C, Renner B, Mieth M, Hoier E, Auge D, Maas R, et al. Journal article Application of the Pareto principle to identify and address drug-therapy safety issues (2014) Müller F, Dormann H, Pfistermeister B, Sonst A, Patapovas A, Vogler R, Hartmann N, et al. Journal article The association of ABCB1 polymorphisms and elevated serum digitoxin concentrations in geriatric patients (2008) Dragonas C, Wagner J, Heppner HJ, Bertsch T, Mühlberg W, Wicklein S, Pahl A, et al. Journal article